Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

DEA Says No to Schedule II for Marijuana

Posted on September 5th, 2016 by in Pharma R&D

This month, in response to petitions from the former governors of Rhode Island and Washington and from a psychiatric nurse in New Mexico, the U.S. Drug Enforcement Agency (DEA) announced its decision to keep marijuana classified as a Schedule I controlled substance. Continue reading “DEA Says No to Schedule II for Marijuana” »